ライフサイエンスコーパス: stabilizing agent

1 selection of a preparation with a different stabilizing agent.

2 XP3 demethylation upon restimulation with no stabilizing agent.

3 ent, or paclitaxel (10 microM) a microtubule-stabilizing agent.

4 reased in the presence of either microtubule stabilizing agent.

5 nhanced compared to that in the absence of a stabilizing agent.

6 -thione (AGTT) was used both as reducing and stabilizing agent.

7 cal trials include cholesterol as a membrane stabilizing agent.

8 zes including 10, 20, and 40 nm with a fixed stabilizing agent.

9 g denatured bovine serum albumin (dBSA) as a stabilizing agent.

10 cells were resistant to taxol, a microtubule stabilizing agent.

11 Acetone acts as a preliminary stabilizing agent.

12 -neuronal cells against taxol, a microtubule-stabilizing agent.

13 l this entropy-costly process using tailored stabilizing agents.

14 combinations of the most commonly used mood-stabilizing agents.

15 h doxantrazole or cromoglycate, which are MC stabilizing agents.

16 sufficient response to monotherapy with mood-stabilizing agents.

17 e (10) represents a new class of microtubule-stabilizing agents.

18 without the use of any external reducing or stabilizing agents.

19 ter exposure to DNA-damaging and microtubule-stabilizing agents.

20 for evaluating activity of putative disease stabilizing agents.

21 hypoxia-inducible factor 1alpha (HIF-1alpha) stabilizing agents.

22 s are a novel class of nontaxane microtubule-stabilizing agents.

23 photochromic molecules acting as dispersion-stabilizing agents.

24 oped to evaluate the efficacy of nanocluster stabilizing agents.

25 e preincubated with or without a microtubule stabilizing agent, 100 microM Taxol, at 37 degrees C for

26 he results support the theory that effective stabilizing agents act by favoring the most compact stru

27 response rate for ixabepilone, a microtubule-stabilizing agent, administered intravenously daily for

28 ing agent, BSA can also function as a strong stabilizing agent against reaggregation of single-layer

29 n the presence of ethylenediamine (EDA) as a stabilizing agent and gold nanorods (Au NRs) at 300 degr

30 ltitargeted prototypes with activities as MT-stabilizing agents and/or inhibitors of the cyclooxygena

31 in yeast and bacteria, indicate that protein stabilizing agents are effective in vivo for correcting

32 ed with microfilament-disrupting or filament-stabilizing agents at levels comparable to those in untr

33 kotriene receptor antagonist, or a mast cell stabilizing agent before exercise.

34 tions that incorporate alpha-tocopherol as a stabilizing agent but there are few studies of the effec

35 These results indicate that not all mood-stabilizing agents but only those, which have anticonvul

36 drugs because they are powerful microtubule-stabilizing agents, but the complexity of their chemical

37 ls was facilitated by use of the protofibril-stabilizing agent calmidazolium chloride.

38 t mouse strains and mice treated with the MC stabilizing agent cromolyn sodium had dramatically reduc

39 (BL-3 cells) with the mitochondrial membrane-stabilizing agent cyclosporine (CSA) reduced LKT-mediate

40 Treatment of cells with taxol, a microtubule stabilizing agent, did not induce MEKK1 cleavage in cell

41 ained without the need for any surfactant or stabilizing agent, due to the strong electrostatic repul

42 ctylbenzene molecules as graphene dispersion-stabilizing agents during the graphite LPE process.

43 ficance in that they allow the separation of stabilizing agent effects on nanocluster formation from

44 terventional study of the brain-penetrant MT-stabilizing agent, epothilone D (EpoD), in aged PS19 mic

45 We demonstrate here that the MT-stabilizing agent, epothilone D (EpoD), is brain-penetra

46 les were also incubated 1 h with microtubule stabilizing agents, epothilone D or discodermolide, foll

47 ptides were further used as the reducing and stabilizing agents for generation of peptide-bound AuNCs

48 ide, we examined combinations of microtubule-stabilizing agents for synergistic effects on tubulin as

49 Lithium is one of the most widely used mood-stabilizing agents for the treatment of bipolar disorder

50 with the Ag clusters and serve as effective stabilizing agents for these clusters.

51 elective synthesis of the potent microtubule-stabilizing agent FR182877 is described.

52 lpha in the cytoplasm, whereas a microtubule-stabilizing agent had no effect.

53 In contrast, treatment with an actin-stabilizing agent had no significant effect on NKCC1 pro

54 As brain-penetrant MT-stabilizing agents have proven effective against tau-med

55 ins form a promising class of quadruplex DNA stabilizing agents having high selectivity for quadruple

56 zation was blocked by the potent microtubule stabilizing agent hexylene glycol, but was unaffected by

57 With a stabilizing agent (i.e., methylene blue and sodium phosp

58 ne B, EPO906), a novel nontaxane microtubule stabilizing agent, in treatment of multiple myeloma (MM)

59 Microtubule-stabilizing agents including Taxol, epothilone B, and di

60 eatments, they are not well defined for mood-stabilizing agents, including lithium.

61 Paclitaxel, a microtubule-stabilizing agent, induces a caspase-dependent apoptosis

62 import by low-dose paclitaxel, a microtubule-stabilizing agent, inhibits cholangiocarcinoma invasiven

63 by mixing different quantities of fruit and stabilizing agents (inulin, pectin and gellan gum), ther

64 ic agent paclitaxel (TaxolTM), a microtubule stabilizing agent, is known to arrest cells at the G2/M

65 he taccalonolides are a class of microtubule stabilizing agents isolated from plants of the genus Tac

66 lly and mechanistically distinct microtubule-stabilizing agents isolated from Tacca chantrieri.

67 The mood-stabilizing agents lithium and valproic acid (VPA) incre

68 ults suggest that certain brain-penetrant MT-stabilizing agents might provide a viable therapeutic st

69 n cancer cell lines resistant to microtubule stabilizing agents (MSAs) and in human tumors resistant

70 Microtubule stabilizing agents (MSAs) comprise a class of drugs that

71 A number of microtubule (MT)-stabilizing agents (MSAs) have demonstrated or predicted

72 One class of drugs, known as microtubule stabilizing agents (MSAs), binds to microtubule polymers

73 Microtubule-stabilizing agents (MTSAs), including the taxanes and ep

74 the DNA-damaging drug doxorubicin or the p53 stabilizing agent Nutlin-3, however, is accompanied by p

75 The presence of stabilizing agents of QDs in the droplet was found to ca

76 ies were performed to examine the effects of stabilizing agents on the transport and retention of ful

77 is a potent, structurally unique microtubule-stabilizing agent originally isolated from the marine sp

78 enhanced in the presence of the microtubule-stabilizing agent paclitaxel (Taxol).

79 suppression of microtubule turnover with the stabilizing agent paclitaxel has no effect on BKV infect

80 in cells treated with either the microtubule-stabilizing agent paclitaxel, or an inactive form of col

81 treatment with a low dose of the microtubule-stabilizing agent paclitaxel.

82 ns, which did not occur with the microtubule-stabilizing agent paclitaxel.

83 SGNs were more sensitive to the microtubule stabilizing agent, paclitaxel.

84 Pretreatment of HPAECs with the actin-stabilizing agent phallacidin attenuated hyperoxia-induc

85 Corneas superfused with the f-actin stabilizing agent phallacidin had significantly lower pe

86 grape extracts (5-20%) and concentration of stabilizing agent (polyvinyl alcohol, PVA: 1-3%).

87 liferation, and treatment with a microtubule stabilizing agent prevented them from occurring.

88 Addition of stabilizing agents prevents loss of the delta but not th

89 otofilaments in the presence of calcium as a stabilizing agent, similar to bacterial FtsZ.

90 nm Au NPs and Ag(+) ions in the presence of stabilizing agents such as adenosine triphosphate (ATP)

91 g bound nucleotide denatures rapidly without stabilizing agents such as sucrose; and second, without

92 To overcome resistance against microtubule stabilizing agents such as taxanes, epothilone B (EpoB)

93 Microtubule-stabilizing agents, such as paclitaxel (Taxol), are effe

94 treated with clinically available mast cell-stabilizing agents suggest the potential of developing n

95 cristin, and vinblastine and the microtubule-stabilizing agent taxol also exhibited 50 to 60% inhibit

96 nocodazole was inhibited by the microtubule-stabilizing agent Taxol but not by pretreatment with a c

97 The microtubule-stabilizing agent Taxol did not mimic this effect, sugge

98 colchicine and attenuated by the microtubule-stabilizing agent taxol.

99 one toxicity was occluded by the microtubule-stabilizing agent Taxol.

100 an increased sensitivity to the microtubule-stabilizing agent taxol.

101 roduct from marine sponges, is a microtubule-stabilizing agent that binds to tubulin at a site distin

102 Discodermolide is a microtubule-stabilizing agent that induces accelerated cell senescen

103 Paclitaxel (PTX) is a microtubule-stabilizing agent that is widely used in cancer chemothe

104 in the axons of neurons, is an endogenous MT-stabilizing agent that plays an important role in axonal

105 Lithium and valproic acid are mood-stabilizing agents that are often used to manage the epi

106 identification of alternative CNS-active MT-stabilizing agents that lack these potential limitations

107 s better than a current, widely used protein stabilizing agent, trehalose.

108 ted ARF is unknown, it may be related to the stabilizing agent used in the IVIG preparation.

109 modulate kinesin motility regardless of the stabilizing agent used.

110 compare it with cromolyn sodium, a mast cell stabilizing agent with established efficacy in EIA.

111 ing macrolides known to act as a microtubule stabilizing agent with properties similar to Taxol.

112 ts with bipolar disorder who received a mood stabilizing agent with versus without an antidepressant

113 he design and synthesis of other microtubule-stabilizing agents with a similar capacity.

114 imalide represent a new class of microtubule-stabilizing agents with activities that may provide ther

115 ee of additives or containing Irgafos 168 as stabilizing agent without any sampling step.